Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

23 Jul, 2024

 Pfizer Unveils $1 Billion Manufacturing Facility in Tuas Biomedical Park

Pfizer has opened a new $1 billion Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas Biomedical Park, Singapore. The 429,000 sq ft facility will produce small molecule APIs for oncology, pain, and antibiotic medicines, creating over 250 jobs. Designed for future expansions, it includes processing suites, a warehouse, and energy-efficient technologies. The facility holds a Green Mark Gold certification, underscoring Pfizer's commitment to sustainability.

Related News

Singapore Hosts TMS APAC 2025, Driving Business Tourism Growth Globally

03 Apr, 2025

The Meetings Show Asia Pacific (TMS APAC) 2025 returns for…
Read More
Singapore and Vietnam Strengthen Economic and Strategic Ties During PM Visit

26 Mar, 2025

Singaporean Prime Minister Lawrence Wong will make his first official…
Read More
Singapore and India Strengthen Ties in Green Shipping, Digital Business

20 Mar, 2025

India’s Minister of Ports, Shipping, and Waterways, Sarbananda Sonowal, along…
Read More
Singapore and Thailand Boost Economic Ties Through Strategic Business Partnerships

19 Mar, 2025

Singapore and Thailand are strengthening economic ties through strategic business…
Read More
Vietnam-Singapore Strengthen Economic Ties with Comprehensive Strategic Partnership

13 Mar, 2025

Singapore and Vietnam have officially elevated their bilateral relations to…
Read More
Rwanda-Singapore Partnership Boosts Digital Economy and Innovation

11 Mar, 2025

Rwanda and Singapore are strengthening their partnership to drive digital…
Read More

Interview

© 2025 Business International News. All rights reserved | Powered by Cred Matters.